LABFF
Price
$90.61
Change
+$4.56 (+5.30%)
Updated
Jul 1 closing price
XTLB
Price
$1.55
Change
-$0.02 (-1.27%)
Updated
Dec 18, 03:54 PM (EDT)
Ad is loading...

LABFF vs XTLB

Header iconLABFF vs XTLB Comparison
Open Charts LABFF vs XTLBBanner chart's image
LABORATORIOS FARMACEUTICOS ROVI SA
Price$90.61
Change+$4.56 (+5.30%)
Volume$100
CapitalizationN/A
XTL Biopharmaceuticals
Price$1.55
Change-$0.02 (-1.27%)
Volume$136
CapitalizationN/A
LABFF vs XTLB Comparison Chart
Loading...
View a ticker or compare two or three
VS
LABFF vs. XTLB commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LABFF is a Hold and XTLB is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (LABFF: $90.61 vs. XTLB: $1.57)
Brand notoriety: LABFF and XTLB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LABFF: 100% vs. XTLB: 18%
Market capitalization -- LABFF: $3.31B vs. XTLB: $8.5M
LABFF [@Biotechnology] is valued at $3.31B. XTLB’s [@Biotechnology] market capitalization is $8.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LABFF’s FA Score shows that 2 FA rating(s) are green whileXTLB’s FA Score has 0 green FA rating(s).

  • LABFF’s FA Score: 2 green, 3 red.
  • XTLB’s FA Score: 0 green, 5 red.
According to our system of comparison, LABFF is a better buy in the long-term than XTLB.

Price Growth

LABFF (@Biotechnology) experienced а 0.00% price change this week, while XTLB (@Biotechnology) price change was -7.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

XTLB is expected to report earnings on Dec 03, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
LABFF($3.31B) has a higher market cap than XTLB($8.5M). LABFF YTD gains are higher at: 74.250 vs. XTLB (54.935).
LABFFXTLBLABFF / XTLB
Capitalization3.31B8.5M38,890%
EBITDAN/AN/A-
Gain YTD74.25054.935135%
P/E Ratio28.85N/A-
RevenueN/AN/A-
Total CashN/A133K-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
XTLB: Fundamental Ratings
XTLB
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
4

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

LABFF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LABFF has been closely correlated with XTLB. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if LABFF jumps, then XTLB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LABFF
1D Price
Change %
LABFF100%
N/A
XTLB - LABFF
70%
Closely correlated
-6.29%
ELVN - LABFF
39%
Loosely correlated
+3.48%
CRNX - LABFF
35%
Loosely correlated
+1.35%
TOVX - LABFF
27%
Poorly correlated
+1.71%
BCLI - LABFF
26%
Poorly correlated
+15.48%
More

XTLB and

Correlation & Price change

A.I.dvisor indicates that over the last year, XTLB has been closely correlated with LABFF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if XTLB jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTLB
1D Price
Change %
XTLB100%
-6.29%
LABFF - XTLB
70%
Closely correlated
N/A
SER - XTLB
59%
Loosely correlated
+15.42%
ENTBF - XTLB
29%
Poorly correlated
-2.20%
SOLTF - XTLB
26%
Poorly correlated
-2.01%
TOVX - XTLB
26%
Poorly correlated
+1.71%
More